Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.
about
Early versus delayed postoperative radiotherapy for treatment of low-grade gliomasMagnetic resonance perfusion for differentiating low grade from high grade gliomas at first presentationBiopsy versus resection for the management of low-grade gliomasPharmacological treatment of depression in patients with a primary brain tumourPharmacological treatment of depression in patients with a primary brain tumourRecent advancements in multimodality treatment of gliomasSeizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic reviewClinical Management of Seizures in Patients With Low-Grade GliomaIntegration of epidemiology, immunobiology, and translational research for brain tumorsSeizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials.New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach.Survival and low-grade glioma: the emergence of genetic informationManagement of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors.Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.Management of low-grade glioma.Effect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade glioma.Therapeutic decision making in patients with newly diagnosed low grade glioma.Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy.Imaging biomarkers in primary brain tumours.Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.Trends and Outcomes in the Treatment of Gliomas Based on Data during 2001–2004 from the Brain Tumor Registry of Japan.Predictive and prognostic markers in neuro-oncology.Temozolomide: a milestone in neuro-oncology and beyond?Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.Prospective evaluation of the palliative effect of whole-brain radiotherapy in patients with brain metastases and poor performance status.miR-10a and miR-204 as a Potential Prognostic Indicator in Low-Grade Gliomas.Health-related quality of life in glioma patients in China.Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspectiveOligodendrogliomas in pediatric and adult patients: an outcome-based study from the Surveillance, Epidemiology, and End Result databaseRandomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.Conversion of a molecular classifier obtained by gene expression profiling into a classifier based on real-time PCR: a prognosis predictor for gliomasGliomas in adults.First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response.Clinical prognostic factors of adjuvant radiation therapy for low-grade gliomas: results of 10 years survivalSeizure prognosis in brain tumors: new insights and evidence-based managementDoes early resection of presumed low-grade glioma improve survival? A clinical perspective.Prognostic factors in intramedullary astrocytomas: a literature review.Central nervous system cancersAutologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas.
P2860
Q24186964-F7E06305-3A71-41A3-9088-2AC66C98D975Q24187505-DAD013AF-71CB-406A-8187-4C4A2887EE87Q24197750-439856BC-AA47-439C-9B60-0BF46508E0CEQ24202721-BA93A6DF-6AEE-4578-88E1-7285745E12FBQ24236728-9B5FF87F-3517-4D55-AFDF-B80E1252B7D9Q27001724-E6D12BD6-BE2F-4510-B606-168EA13430D2Q27027730-5C6D23CB-B9CC-44BE-A3FC-4F701D6C3E7CQ28082498-92C257F4-9BAA-44FC-BED4-F7C3C163980EQ28397886-E6B2DBA5-4736-4C38-906A-6D02D8446D6AQ30275879-D9961D01-A529-401C-90B3-9474079C2019Q30365386-3BF9BCC6-DA2C-4487-A50A-6B6C93A8BDD1Q30395017-209D9F83-B68D-47D8-9F30-3573F2D76416Q30417015-0A5ADEFF-CB35-48E2-8735-C8CA7679CB69Q30425164-4FC1048D-ABD0-4FDC-AEBF-C0BEA2C86AEFQ30436353-402E0B9A-BB55-4A6E-B952-BB7DE3ED2807Q30458648-528C8C9B-20F4-461C-B6EB-B5B4852B44E4Q30458916-EDE04E18-DC8E-4227-8A7A-3B3E0DC74B19Q30607148-660896B9-D7B6-4141-94FB-557E61067ACCQ30880129-CEB349AB-AE14-466D-B569-B4DE2638B0BBQ30967370-F0707A72-5C6C-4E9B-8DDA-1F3CC5EC16E3Q30984635-6B22B871-004E-42F4-B04A-9521BA9BCB85Q33311133-B33BB983-C454-424D-AAD4-355E63F8BE12Q33372340-453509E8-1BAF-492D-8553-71F3B9AB7308Q33399939-8CEC6E92-FADC-4BEC-9A1F-7B510725FF29Q33447142-653D5F5E-ADDE-4E6D-8FE3-C788A32F3342Q33557396-A9B4BF83-0FC9-403C-8421-96D628CD5D0FQ33580633-50E35AC9-A9B1-4685-9F62-F1FD502F078BQ33611220-AA41A1B2-A7F0-47F4-917A-B809184FD635Q33636469-09819A1F-2574-4B40-80B0-3FF6261698EBQ33649896-1FCC859E-E646-4231-B1FF-F4336CBAF672Q33711607-9EC5D7D0-9D65-459F-8664-B55F5D7F5BDDQ33742873-710FB6AA-E14D-40F4-8BE1-E57F84EDB446Q33760539-CF7FBDC2-ABE1-40AC-9A23-B3C6145350C6Q33777877-D829C027-7A03-43E9-BDCC-BA0B9EF996BBQ33815954-D8ECEF69-68C7-4795-84EA-8BB5324E3FAFQ33829789-0ED85454-56E9-49E8-B856-CD7AE3E3BA06Q33867304-73FBB423-C20F-4FEF-856D-84CC1EEFEE77Q33971939-8112A52E-947A-4C0B-952C-53537E00EDCAQ34014740-CBA13924-C9FB-4B21-A4F0-33957D675555Q34439167-261D7DD4-326D-4347-9E17-61373F304714
P2860
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Long-term efficacy of early ve ...... EORTC 22845 randomised trial.
@ast
Long-term efficacy of early ve ...... EORTC 22845 randomised trial.
@en
type
label
Long-term efficacy of early ve ...... EORTC 22845 randomised trial.
@ast
Long-term efficacy of early ve ...... EORTC 22845 randomised trial.
@en
prefLabel
Long-term efficacy of early ve ...... EORTC 22845 randomised trial.
@ast
Long-term efficacy of early ve ...... EORTC 22845 randomised trial.
@en
P2093
P1433
P1476
Long-term efficacy of early ve ...... EORTC 22845 randomised trial.
@en
P2093
A B M F Karim
EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council
K Hoang-Xuan
L Collette
M Ben Hassel
M J van den Bent
O de Witte
P-O Malmström
P304
P356
10.1016/S0140-6736(05)67070-5
P407
P577
2005-09-01T00:00:00Z